secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001178913-24-002393
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio shareholders approve all 8 proposals at 2024 annual meeting
----------------------------------------------------------------------

- Elected Miranda Toledano and Yonatan Malca to three-year board terms with ~99% of votes cast.
- Approved one-time CEO compensation grant for Miranda Toledano (14,365,894 for, 544,357 against).
- Approved amendment to 2018 Equity Incentive Plan, increasing shares by 1,788,515 (14,131,640 for).
- Ratified Kesselman & Kesselman (PwC) as independent auditors for FY2024 with overwhelming support.
- Advisory vote on executive compensation passed; the most frequent frequency vote was 'one year'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891324002393/0001178913-24-002393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891324002393/zk2431764.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-002393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer